The DOI matches its Crossref record; 263 of the 263 references it cites were found in a registry or an index.
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Open accessAbstract
Cholangiocarcinomas are a heterogeneous group of bile duct cancers and the second most common primary liver tumour worldwide. In this Consensus statement, the newly formed European Network for the Study of Cholangiocarcinoma (ENS-CCA) detail the classification, pathophysiology and underlying mechanisms, and current therapies for cholangiocarcinoma, as well as future perspectives. Cholangiocarcinoma (CCA) is a heterogeneous group of malignancies with features of biliary tract differentiation. CCA is the second most common primary liver tumour and the incidence is increasing worldwide. CCA has high mortality owing to its aggressiveness, late diagnosis and refractory nature. In May 2015, the “European Network for the Study of Cholangiocarcinoma” (ENS-CCA: www.enscca.org or www.cholangiocarcinoma.eu ) was created to promote and boost international research collaboration on the study of CCA at basic, translational and clinical level. In this Consensus Statement, we aim to provide valuable information on classifications, pathological features, risk factors, cells of origin, genetic and epigenetic modifications and current therapies available for this cancer. Moreover, future directions on basic and clinical investigations and plans for the ENS-CCA are highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–263 of 263
Kanno, N., Glaser, S. S., Chowdhury, U., Phinizy, J. L., Baiocchi, L., Francis, H., LeSage, G., & Alpini, G. D. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00025-8 · Cited by 70
Menakongka, A. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i6.713 · Cited by 69
Alvaro, D., Macarri, G., Mancino, M. G., Marzioni, M., Bragazzi, M. C., Onori, P., Corradini, S. G., Invernizzi, P., Franchitto, A., Attili, A. F., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00003 · Cited by 69
Self-citationChen, W., Tseng, C.-C., Pfaffenbach, K. T., Kanel, G. C., Luo, B., Stiles, B. L., & Lee, A. S. (2013) · Hepatology · doi:10.1002/hep.26711 · Cited by 66
Molecular Bases of Chemoresistance in Cholangiocarcinoma
Marín, J. J. G., Lozano, E., Briz, Ó., Al‐Abdulla, R., Serrano, M. A., & Macías, R. I. R. (2015) · Current Drug Targets · doi:10.2174/1389450116666150223121508 · Cited by 64
Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis: A 24-Year Experience
Morris-Stiff, G., Bhati, C. S., Olliff, S. P., Hübscher, S. G., Gunson, B. K., Mayer, D., Mirza, D. F., Buckels, J. A. C., & Bramhall, S. R. (2008) · Digestive Surgery · doi:10.1159/000128169 · Cited by 61
Nakajima, T., Takayama, T., Miyanishi, K., Nobuoka, A., Hayashi, T., Abe, T., Kato, J., Sakon, K., Naniwa, Y., Tanabe, H., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052696 · Cited by 61
Cholangiocarcinoma in Young Individuals With and Without Primary Sclerosing Cholangitis
Björnsson, E. S., & Angulo, P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01220.x · Cited by 60
Increased local dopamine secretion has growth‐promoting effects in cholangiocarcinoma
Coufal, M., Invernizzi, P., Gaudio, E., Bernuzzi, F., Frampton, G. A., Onori, P., Franchitto, A., Carpino, G., Ramirez, J. C., Alvaro, D., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24909 · Cited by 60
Self-citationFranchitto, A., Onori, P., Renzi, A., Carpino, G., Mancinelli, R., Alvaro, D., & Gaudio, E. (2013) · PubMed · doi:10.3978/j.issn.2305-5839.2012.10.03 · Cited by 60
Self-citationCampbell, W. L., Peterson, M. S., Federle, M. P., Siqueira, E. S., Slivka, A., Grazioli, L., Ichikawa, T., Oliver, J. H., Kim, T., & Li, W. (2001) · American Journal of Roentgenology · doi:10.2214/ajr.177.5.1771095 · Cited by 59
Techasen, A., Loilome, W., Namwat, N., Dokduang, H., Jongthawin, J., & Yongvanit, P. (2012) · PubMed · Cited by 58
Microsatellite instability and alternative genetic pathway in intrahepatic cholangiocarcinoma
Momoi, H., Itoh, T., Nozaki, Y., Arima, Y., Okabe, H., Satoh, S., Toda, Y., Sakai, E., Nakagawara, K.-I., Flemming, P., et al. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00106-4 · Cited by 57
N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas
Mosnier, J., Kandel, C., Cazals-Hatem, D. L., Bou‐Hanna, C., Gournay, J., Jarry, A., & LABOISSE, C. L. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.123 · Cited by 56
Estrogen Stimulates Female Biliary Epithelial Cell Interleukin-6 Expression in Mice and Humans
Isse, K., Specht, S. M., Lunz, J. G., Kang, L., Mizuguchi, Y., & Demetris, A. J. (2009) · Hepatology · doi:10.1002/hep.23386 · Cited by 56
Borbath, I., Verbrugghe, L., Lai, R. L., Gigot, J. F., Humblet, Y., Piessevaux, H. H., & Sempoux, C. L. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.11.006 · Cited by 55
Liver transplantation for cholangiocarcinoma: Selection is essential for acceptable results
Friman, S., Foss, A. E., Isoniemi, H., Olausson, M., Höckerstedt, K., Yamamoto, S., Karlsen, T. H., Rizell, M., & Ericzon, B. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2010.533384 · Cited by 55
Obama, K., Satoh, S., Hamamoto, R., Sakai, Y., Nakamura, Y., & Furukawa, Y. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1381 · Cited by 55
Molecular identification and functional characterization of Mdr1a in rat cholangiocytes
Gigliozzi, A., Fraioli, F., Sundaram, P., Lee, J., Mennone, A., Alvaro, D., & Boyer, J. L. (2000) · Gastroenterology · doi:10.1053/gast.2000.18156 · Cited by 52
Self-citationCharacterization of 5-Fluorouracil-Resistant Cholangiocarcinoma Cell Lines
Namwat, N., Amimanan, P., Loilome, W., Jearanaikoon, P., Sripa, B., Bhudhisawasdi, V., & Tassaneeyakul, W. (2008) · Chemotherapy · doi:10.1159/000151541 · Cited by 52
Lautem, A., Heise, M., GRÄSEL, A., Hoppe‐Lotichius, M., Weiler, N., Foltys, D. B., Knapstein, J., Schattenberg, J. M., Schad, A., Zimmermann, A., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1840 · Cited by 52
Zaydfudim, V. M., Rosen, C. B. B., & Nagorney, D. M. (2014) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2013.10.005 · Cited by 52
Metformin inhibits tumor growth by regulating multiple miRNAs in human cholangiocarcinoma
Jiang, X., Ma, N., Wang, D., Li, F., He, R., Li, D., Zhao, R., Zhou, Q., Wang, Y., Zhang, F., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.3063 · Cited by 51
Endogenous Opioids Modulate the Growth of the Biliary Tree in the Course of Cholestasis
Marzioni, M., Alpini, G. D., Saccomanno, S., Minicis, S. D., Glaser, S. S., Francis, H., Trozzi, L., Venter, J., Orlando, F., Fava, G., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.021 · Cited by 51
Self-citationMolecular Mechanisms of Tamoxifen Therapy for Cholangiocarcinoma: Role of Calmodulin
Pawar, P., Ma, L., Byon, C. H., Liu, H., Ahn, E.-Y. E., Jhala, N. C., Arnoletti, J. P., McDonald, J. M., & Chen, Y. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1150 · Cited by 51
Hepatitis B virus infection and intrahepatic cholangiocarcinoma
Zhou, H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i19.5721 · Cited by 51
Wu, W., ZHANG, R., Shi, X.-D., Zhu, M.-S., Xu, L., ZENG, H., & Liu, C. (2014) · Oncology Reports · doi:10.3892/or.2014.3123 · Cited by 50
Difficult Diagnostic Problems in Pancreatobiliary Neoplasia
Bledsoe, J. R., Shinagare, S. A., & Deshpande, V. (2015) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0205-ra · Cited by 47
Bile proteomics for differentiation of malignant from benign biliary strictures: a pilot study
Navaneethan, U., Lourdusamy, V., Venkatesh, P. G. K., Willard, B. B., Sanaka, M. R., & Parsi, M. A. (2014) · Gastroenterology report · doi:10.1093/gastro/gou066 · Cited by 47
Navaneethan, U., Parsi, M. A., Lourdusamy, V., Bhatt, A., Gutierrez, N. G., Grove, D., Sanaka, M. R., Hammel, J., Stevens, T., Vargo, J. J., et al. (2014) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.09.041 · Cited by 46
Expression and Antitumor Effects of TRAIL in Human Cholangiocarcinoma
Tanaka, S., Sugimachi, K., Shirabe, K., Shimada, M., Wands, J. R., & Sugimachi, K. (2000) · Hepatology · doi:10.1053/jhep.2000.9716 · Cited by 46
Triptolide sensitizes resistant cholangiocarcinoma cells to TRAIL-induced apoptosis.
Panichakul, T., Intachote, P., Wongkajorsilp, A., Sripa, B., & Sirisinha, S. (2006) · PubMed · Cited by 46
Hedgehog Signaling Between Cancer Cells and Hepatic Stellate Cells in Promoting Cholangiocarcinoma
Kim, Y., Kim, M.-O., Shin, J. S., Park, S. H., Kim, S. B., Kim, J., Park, S. C., Han, C. J., Ryu, J. K., Yoon, Y. B., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3531-y · Cited by 45
Gene expression analysis for predicting gemcitabine resistance in human cholangiocarcinoma
Sato, J., Kimura, T., Saito, T., Anazawa, T., Kenjo, A., Sato, Y., Tsuchiya, T., & Gotoh, M. (2011) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1007/s00534-011-0376-7 · Cited by 44
The roles of Notch1 expression in the migration of intrahepatic cholangiocarcinoma
Zhou, Q., Wang, Y., Peng, B., Liang, L., & Li, J. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-244 · Cited by 44
Lozano, E., Monte, M. J., Briz, Ó., Hernández‐Hernández, Á., Bañales, J. M., Marı́n, J. J. G., & Macı́as, R. I. R. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.022 · Cited by 43
Limpaiboon, T., Khaenam, P., Chinnasri, P., Soonklang, M., Jearanaikoon, P., Sripa, B., Pairojkul, C., & Bhudhisawasdi, V. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.020 · Cited by 42
Frampton, G. A., Coufal, M., Huang, L., Ramirez, J. C., & DeMorrow, S. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.03.017 · Cited by 42
Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma
Fingas, C. D., Mertens, J. C., Razumilava, N., Sydor, S., Bronk, S. F., Christensen, J. D., Rizvi, S. H., Canbay, A. E., Treckmann, J. W., Paul, A., et al. (2013) · Hepatology · doi:10.1002/hep.26484 · Cited by 41
Self-citationMolecular Pathogenesis of Cholangiocarcinoma
Rizvi, S. H., & Gores, G. J. (2014) · Digestive Diseases · doi:10.1159/000360502 · Cited by 41
Fava, G., DeMorrow, S., Gaudio, E., Franchitto, A., Onori, P., Carpino, G., Glaser, S. S., Francis, H., Coufal, M., Marucci, L., et al. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.01997.x · Cited by 38
Self-citationMarzioni, M., Torrice, A., Saccomanno, S., Rychlicki, C., Agostinelli, L., Pierantonelli, I., Rhonnstad, P., Trozzi, L., Apelqvist, T., Gentile, R., et al. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.06.014 · Cited by 38
Self-citationJuntermanns, B., Sotiropoulos, G. C., Radünz, S., Reis, H., Heuer, M., Baba, H. A., Canbay, A. E., Schüler, M., Gerken, G., Paul, A., et al. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2486-0 · Cited by 36
Shirabe, K., Shimada, M., Tsujita, E., Aishima, S.-I., Maehara, S., Tanaka, S., Takenaka, K., & Maehara, Y. (2004) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2003.12.044 · Cited by 36
Ryu, H. S., Chung, J.-H., Lee, K., Shin, E., Jin, J., Choe, G., Kim, H., Xu, X., Lee, H. E., Kim, D. G., et al. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.07.004 · Cited by 33
Hwang, I. G., Jang, J.-S., Do, J. H., Kang, J. H., Lee, G. W., Oh, S. Y., Kwon, H.-C., Jun, H. J., Lim, H. Y., Lee, S., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1558-3 · Cited by 30
Hahnvajanawong, C. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i30.3955 · Cited by 30
Recent advances in the regulation of cholangiocarcinoma growth
Francis, H., Alpini, G. D., & DeMorrow, S. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00114.2010 · Cited by 29
An update on cholangiocarcinoma associated with primary sclerosing cholangitis
Fevery, J., & Verslype, C. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328337b311 · Cited by 28
Lu, D., Han, C. L., & Wu, T. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.056 · Cited by 28
High expression of ABCC1 indicates poor prognosis in intrahepatic cholangiocarcinoma.
Srimunta, U., Sawanyawisuth, K., Kraiklang, R., Pairojkul, C., Puapairoj, A., Titipungul, T., Hahnvajanawong, C., Tassaneeyakul, W., Wongkham, C., Wongkham, S., et al. (2012) · PubMed · Cited by 26
Habara, K., Ajiki, T., Kamigaki, T., Nakamura, T., & KURODA, Y. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01068.x · Cited by 24
Cao, L., Duchrow, M., Windhövel, U., Kujath, P., Bruch, H. ‐., & Broll, R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00142-7 · Cited by 24
Fernandez, T. F., Samal, A. B., Bedwell, G. J., Chen, Y., & Saad, J. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.471821 · Cited by 22
Patel, T. C. (2014) · Hepatology · doi:10.1002/hep.27185 · Cited by 18
Simvastatin enhances the chemotherapeutic efficacy of S-1 against bile duct cancer
Cai, J., Chen, W., Hou, X., Liang, L., Hao, X., & Yin, X. (2013) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328364f935 · Cited by 15
Association of stem cell marker expression pattern and survival in human biliary tract cancer
Kemmerling, R., Alinger, B., Dietze, O., Bösmüller, H.-C., Ocker, M., Wolkersdörfer, G. W., Berr, F., Neureiter, D., & Kiesslich, T. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1477 · Cited by 14
Ge, X., Wang, Y., Li, Q., Yu, H., Ji, G., & Miao, L. (2013) · Oncology Reports · doi:10.3892/or.2013.2427 · Cited by 13
XIAP Antagonist Embelin Inhibited Proliferation of Cholangiocarcinoma Cells
Wehrkamp, C. J., Gutwein, A. R., Natarajan, S. K., Phillippi, M. A., & Mott, J. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090238 · Cited by 13
Cholangiocarcinoma development: The resurgence of bile acids
Maroni, L., Alpini, G. D., & Marzioni, M. (2014) · Hepatology · doi:10.1002/hep.27223 · Cited by 12
Self-citationBiliary Stent Therapy for Dominant Strictures in Patients Affected by Primary Sclerosing Cholangitis
Abu‐Wasel, B., Keough, V., Renfrew, P. D., & Molinari, M. (2013) · Pathobiology · doi:10.1159/000347057 · Cited by 12
Kelley, R. K., Hirose, R., & Venook, A. P. (2012) · Liver Transplantation · doi:10.1002/lt.23423 · Cited by 6
A new mouse model that closely resembles human cholangiocarcinoma
Leake, I. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.10 · Cited by 1
Cited by
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
Self-citationHuman primary liver cancer–derived organoid cultures for disease modeling and drug screening
Broutier, L., Mastrogiovanni, G., Verstegen, M. M., Francies, H. E., Gavarró, L. M., Bradshaw, C. R., Allen, G. E., Arnes-Benito, R., Sidorova, O., Gaspersz, M. P., et al. (2017) · Nature Medicine · doi:10.1038/nm.4438 · Cited by 1,471
“Thus, EpCAM, was highly expressed in all CCs (CC-1-3) and CHCs (CHC-1-2) tumouroids and corresponding patients’ tissues, but absent on HCCs tumouroids and tissues (Fig.”
InfluentialValle, J. W., Kelley, R. K., Nervi, B., Oh, D.-Y., & Zhu, A. X. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00153-7 · Cited by 1,043
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Jusakul, A., Cutcutache, I., Yong, C. H., Lim, J. Q., Huang, M. N., Padmanabhan, N., Nellore, V., Kongpetch, S., Ng, A. W. T., Ng, L. M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0368 · Cited by 969
Brindley, P. J., Bachini, M., Ilyas, S. I., Khan, S. A., Loukas, A., Sirica, A. E., Teh, B. T., Wongkham, S., & Gores, G. J. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00300-2 · Cited by 841
Metadata
- Authors
- Banales, J. M., Cardinale, V., Carpino, G., Marzioni, M., Andersen, J. B., Invernizzi, P., Lind, G. E., Folseraas, T., Forbes, S. J., Fouassier, L., Geier, A., Calvisi, D. F., Mertens, J. C., Trauner, M., Benedetti, A., Maroni, L., Vaquero, J., Macias, R. I. R., Raggi, C., Perugorria, M. J., Gaudio, E., Boberg, K. M., Marin, J. J. G., & Alvaro, D.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2016-04-20
- Volume
- 13
- Issue
- 5
- Pages
- 261-280
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2337387091
- Cited by
- 1,376
- References
- 263
- FWCI
- 21.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.